X4 Pharmaceuticals (XFOR) Goodwill & Intangibles (2019 - 2025)

X4 Pharmaceuticals' Goodwill & Intangibles history runs 7 years deep, the most recent figure standing at $26.6 million for Q4 2025.

• Quarterly Goodwill & Intangibles fell 2.74% year-over-year to $26.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $26.6 million (down 2.74% YoY) and the FY2025 annual result came in at $26.6 million, down 2.74% from the prior year.
• Goodwill & Intangibles was $26.6 million for Q4 2025 at X4 Pharmaceuticals, down from $26.8 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $27.8 million in Q2 2024 and bottomed at $17.4 million in Q1 2022.
• A 5-year average of $22.2 million and a median of $22.0 million in 2021 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles sank 36.0% — and 2024, when it surged 59.94%.
• X4 Pharmaceuticals' Goodwill & Intangibles stood at $17.4 million in 2021, then dropped by 0.28% to $17.4 million in 2022, then changed by 0.0% to $17.4 million in 2023, then jumped by 57.63% to $27.4 million in 2024, then fell by 2.74% to $26.6 million in 2025.
• Business Quant data shows XFOR's Goodwill & Intangibles at $26.6 million in Q4 2025, $26.8 million in Q3 2025, and $27.0 million in Q2 2025.